EUVIMEDEUVIMED entdecken
Open Access

Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis

Kotaro Oiwa iD, Seiji Watanabe iD, Kazunari Onodera iD, Yohei Iguchi, Yukako Kinoshita iD, Okiru Komine iD, Akira Sobue, Yohei Okada iD, Masahisa Katsuno iD, Koji Yamanaka iD

Science Advances · 2023

DOI: 10.1126/sciadv.adf6895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Kotaro Oiwa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi 464-8601, Japan. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cytoplasmic aggregation of TAR DNA binding protein-43 (TDP-43), also known as TDP-43 pathology, is the pathological hallmark of amyotrophic lateral sclerosis (ALS). However, the mechanism underlying TDP-43 cytoplasmic mislocalization and subsequent aggregation remains unclear. Here, we show that TDP-43 dimerization/multimerization is impaired in the postmortem brains and spinal cords of patients with sporadic ALS and that N-terminal dimerization–deficient TDP-43 consists of pathological inclusion bodies in ALS motor neurons. Expression of N-terminal dimerization–deficient mutant TDP-43 in Neuro2a cells and induced pluripotent stem cell–derived motor neurons recapitulates TDP-43 pathology, such as Nxf1-dependent cytoplasmic mislocalization and aggregate formation, which induces seeding effects. Furthermore, TDP-DiLuc, a bimolecular luminescence complementation reporter assay, could detect decreased N-terminal dimerization of TDP-43 before TDP-43 pathological changes caused by the transcription inhibition linked to aberrant RNA metabolism in ALS. These findings identified TDP-43 monomerization as a critical determinant inducing TDP-43 pathology in ALS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisHumansDNA-Binding ProteinsInclusion BodiesMotor Neurons

Substanzen

DNA-Binding ProteinsTARDBP protein, human

Autor:innen und Institutionen

  • Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi 464-8601, Japan.
  • Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan.
  • Department of Neuroscience and Pathobiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan.
  • Department of Neural iPSC Research, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Aichi 480-1195, Japan.
  • Department of Neurology, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan.
  • Medical Interactive Research and Academia Industry Collaboration Center, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi, Japan.

ORCID-Profile: Kotaro Oiwa, Seiji Watanabe, Kazunari Onodera, Yukako Kinoshita, Okiru Komine, Yohei Okada, Masahisa Katsuno, Koji Yamanaka

Zitieren

APA

Oiwa, K., Watanabe, S., Onodera, K., Iguchi, Y., Kinoshita, Y., Komine, O., Sobue, A., Okada, Y., Katsuno, M., & Yamanaka, K. (2023). Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis. Science Advances. https://doi.org/10.1126/sciadv.adf6895

Vancouver

Oiwa K, Watanabe S, Onodera K, Iguchi Y, Kinoshita Y, Komine O, et al. Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis. Science Advances. 2023. doi:10.1126/sciadv.adf6895

BibTeX
@article{Oiwa2023,
  author = {Oiwa, Kotaro and Watanabe, Seiji and Onodera, Kazunari and Iguchi, Yohei and Kinoshita, Yukako and Komine, Okiru and Sobue, Akira and Okada, Yohei and Katsuno, Masahisa and Yamanaka, Koji},
  title = {Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.adf6895}
}
Kostenlos starten →